Candel Therapeutics, Inc.
Candel Therapeutics, Inc. (CADL) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · CADL · as of Jun 8, 2026
Activity summary
Buy transactions
1
P-Purchase only
Sell transactions
18
12 Months
Buy/Sell ratio
0.06
Buy/Sell (by trades)
Overall sentiment
Candel Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
CADL insider buying and selling by quarter
CADL insider selling · CADL insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · CADL ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
CADL executive sell shares · CADL board member insider trading · CADL insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Feb 23, 2026 | Manning Paul B Director | Purchase | 550,458 | $3.00M⚡ | Form 4 |
| Jul 28, 2025 | Nichols William Garrett Chief Medical Officer | Option | 937 | $1K | Form 4 |
| Jul 28, 2025 | Nichols William Garrett Chief Medical Officer | Sale | 937 | $7K | Form 4 |
| Jun 30, 2025 | Nichols William Garrett Chief Medical Officer | Option | 781 | $1K | Form 4 |
| Jun 30, 2025 | Nichols William Garrett Chief Medical Officer | Sale | 781 | $4K | Form 4 |
| Jun 25, 2025 | Tyagarajan Seshu CTO | Award | 5,353 | $25K | Form 4 |
| Jun 25, 2025 | Tak Paul Peter CEO · Director | Award | 42,826 | $200K | Form 4 |
| Jun 25, 2025 | Manning Paul B Director | Award | 1,070,663 | $5.00M⚡ | Form 4 |
| Jun 25, 2025 | Martell Christopher Director | Award | 111,349 | $520K | Form 4 |
| Jun 25, 2025 | Schoch Charles CFO | Award | 5,353 | $25K | Form 4 |
| Jun 25, 2025 | Loggia Nicoletta Director | Award | 2,141 | $10K | Form 4 |
| Jun 25, 2025 | Nabel Gary J. Director | Award | 5,353 | $25K | Form 4 |
| Jun 25, 2025 | Barone Francesca Chief Scientific Officer | Award | 4,282 | $20K | Form 4 |
| Jun 25, 2025 | PAPA JOSEPH C Director | Award | 64,239 | $300K | Form 4 |
| Mar 18, 2025 | Nichols William Garrett Chief Medical Officer | Option | 13,905 | $18K | Form 4 |
| Mar 18, 2025 | Nichols William Garrett Chief Medical Officer | Option | 4,584 | $17K | Form 4 |
| Mar 18, 2025 | Nichols William Garrett Chief Medical Officer | Sale | 45,316 | $397K | Form 4 |
| Mar 18, 2025 | Barone Francesca Chief Scientific Officer | Option | 18,000 | $28K | Form 4 |
| Mar 18, 2025 | Barone Francesca Chief Scientific Officer | Sale | 32,146 | $282K | Form 4 |
| Mar 18, 2025 | Tak Paul Peter CEO · Director | Sale | 25,772 | $226K | Form 4 |
| Mar 19, 2025 | Tak Paul Peter CEO · Director | Sale | 400 | $4K | Form 4 |
| Mar 17, 2025 | Tyagarajan Seshu CTO | Sale | 31,278 | $276K | Form 4 |
| Mar 17, 2025 | Schoch Charles See Remarks | Sale | 5,000 | $44K | Form 4 |
| Jan 15, 2025 | Barone Francesca Chief Scientific Officer | Sale | 13,534 | $98K | Form 4 |
| Jan 15, 2025 | Tyagarajan Seshu CTO | Sale | 14,322 | $103K | Form 4 |
Nichols William Garrett
Chief Medical Officer
Date
Jul 28
Shares
937
Price
$1.29
Value
$1K
Nichols William Garrett
Chief Medical Officer
Date
Jul 28
Shares
937
Price
$6.98
Value
$7K
Nichols William Garrett
Chief Medical Officer
Date
Jun 30
Shares
781
Price
$1.29
Value
$1K
Nichols William Garrett
Chief Medical Officer
Date
Jun 30
Shares
781
Price
$5.04
Value
$4K
Barone Francesca
Chief Scientific Officer
Date
Jun 25
Shares
4,282
Price
$4.67
Value
$20K
Nichols William Garrett
Chief Medical Officer
Date
Mar 18
Shares
13,905
Price
$1.29
Value
$18K
Nichols William Garrett
Chief Medical Officer
Date
Mar 18
Shares
4,584
Price
$3.75
Value
$17K
Nichols William Garrett
Chief Medical Officer
Date
Mar 18
Shares
45,316
Price
$8.76
Value
$397K
Barone Francesca
Chief Scientific Officer
Date
Mar 18
Shares
18,000
Price
$1.55
Value
$28K
Barone Francesca
Chief Scientific Officer
Date
Mar 18
Shares
32,146
Price
$8.76
Value
$282K
Barone Francesca
Chief Scientific Officer
Date
Jan 15
Shares
13,534
Price
$7.22
Value
$98K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About CADL insider trading
CADL insider trades
Candel Therapeutics, Inc. (CADL) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Nichols William Garrett (Chief Medical Officer), Manning Paul B (Director), Tyagarajan Seshu (CTO). Over the past 12 months, 5 insiders have filed transactions with the SEC. CADL insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Candel Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
CADL insider trading · 5 questionsThe insiders of Candel Therapeutics, Inc. (CADL) include executives and directors such as Nichols William Garrett (Chief Medical Officer), Manning Paul B (Director), Tyagarajan Seshu (CTO), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026